6 drug(s) with this reaction
99,710 total reports
Injection Site Pain has been reported as an adverse reaction across 6 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 99,710 adverse event reports mention injection site pain in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with injection site pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have injection site pain listed in their FDA adverse event reports, sorted by report count:
In addition to injection site pain, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
6 drug(s) manufactured by Abbvie Inc have injection site pain listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, RISANKIZUMAB-RZAA, FENOFIBRATE, and others.
There are a combined 99,710 reports of injection site pain across 6 Abbvie Inc drug(s) in the FDA adverse event database.